デフォルト表紙
市場調査レポート
商品コード
1728139

タンパク質同定市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別、用途別、最終用途別、地域別、競合別、2020-2030年

Protein Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product & Services, By Application, By End-Use, By Region and Competition, 2020-2030F


出版日
ページ情報
英文 185 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

タンパク質同定市場- 世界の産業規模、シェア、動向、機会、予測、製品・サービス別、用途別、最終用途別、地域別、競合別、2020-2030年
出版日: 2025年05月16日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のタンパク質同定市場は、2024年には63億5,000万米ドルと評価され、2030年には131億8,000万米ドルに達し、CAGR 12.92%で成長すると予測されています。

この成長の主な要因は、細胞機能や疾病メカニズムの解明を目的としたプロテオミクスへの注目が高まっていることです。バイオマーカーや治療標的として重要な役割を果たすタンパク質は、医薬品開発、診断、個別化医療の進歩に不可欠です。その結果、バイオテクノロジー企業や製薬企業は、質量分析、電気泳動、クロマトグラフィーなどの高度なタンパク質分析ツールに多額の投資を行っています。精密医療と生物製剤の需要は、正確なタンパク質プロファイリングの必要性を加速させています。さらに、ライフサイエンス研究に対する政府の資金援助や、学界と産業界の協力関係の強化が、市場の拡大を後押ししています。

市場概要
予測期間 2026-2030
市場規模:2024年 63億5,000万米ドル
市場規模:2030年 131億8,000万米ドル
CAGR:2025年~2030年 12.92%
急成長セグメント 創薬・医薬品開発
最大市場 北米

市場促進要因

生物製剤とバイオシミラーの需要増加

主な市場課題

機器と分析サービスの高コスト

主な市場動向

モノクローナル抗体と生物製剤開発の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のタンパク質同定市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品・サービス別(消耗品、機器、サービス)
    • 用途別(創薬・開発、臨床診断、その他)
    • 用途別(製薬・バイオテクノロジー企業、学術調査機関、受託調査機関、その他)
    • 企業別(2024)
    • 地域別
  • 市場マップ

第6章 北米のタンパク質同定市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のタンパク質同定市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のタンパク質同定市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域:国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のタンパク質同定市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのタンパク質同定市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第14章 競合情勢

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • Merck KGAA
  • Promega Corporation
  • Qiagen N.V.
  • Sartorius AG

第15章 戦略的提言

第16章 調査会社について・免責事項

目次
Product Code: 29095

The Global Protein Identification Market was valued at USD 6.35 billion in 2024 and is projected to reach USD 13.18 billion by 2030, growing at a CAGR of 12.92%. This growth is primarily driven by the increasing focus on proteomics for understanding cellular functions and disease mechanisms. Proteins, serving as vital biomarkers and therapeutic targets, are critical to advancements in drug development, diagnostics, and personalized medicine. As a result, biotechnology and pharmaceutical firms are investing heavily in advanced protein analysis tools such as mass spectrometry, electrophoresis, and chromatography. The demand for precision medicine and biologics is accelerating the need for accurate protein profiling. In addition, government funding for life sciences research and stronger collaborations between academia and industry are reinforcing market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.35 Billion
Market Size 2030USD 13.18 Billion
CAGR 2025-203012.92%
Fastest Growing SegmentDrug Discovery & Development
Largest MarketNorth America

Key Market Drivers

Rising Demand for Biologics and Biosimilars

The growing demand for biologics and biosimilars is a major factor driving the Global Protein Identification Market. Biologics such as monoclonal antibodies, therapeutic proteins, and vaccines are transforming the treatment landscape for diseases like cancer, autoimmune conditions, and genetic disorders. Accurate protein identification and characterization are essential to ensure the safety, quality, and efficacy of these therapies. In 2023, the FDA approved 55 new drugs, including 17 biologics, of which 12 were monoclonal antibodies. Similarly, the EMA recommended 77 medicines for marketing authorization, with 39 containing a new active substance, underscoring the focus on biologics. These developments reflect the expanding pipeline of biologic therapies, further increasing the need for advanced protein analysis tools in both development and regulatory processes.

Key Market Challenges

High Cost of Instruments and Analytical Services

One of the primary challenges in the Global Protein Identification Market is the high cost associated with advanced instruments and analytical services. Tools like mass spectrometers, chromatography systems, and protein analyzers are essential but expensive, posing financial barriers for smaller labs and institutions, particularly in emerging regions. The total cost includes not only the initial investment but also ongoing maintenance, consumables, and the requirement for skilled personnel. Moreover, the complexity of protein analysis demands advanced training and expertise, adding to operational expenses. Due to these high costs, many entities opt to outsource services, which can further elevate expenses and limit frequent use. This cost barrier can slow adoption, especially in areas with limited research funding, highlighting the need for more affordable and accessible technologies.

Key Market Trends

Rise in Monoclonal Antibody and Biologics Development

The growing emphasis on monoclonal antibodies (mAbs) and biologic therapies is significantly influencing the Global Protein Identification Market. As mAbs become more prevalent in treating chronic illnesses and cancers, detailed protein analysis is essential for understanding their structures, interactions, and therapeutic potential. The complexity of biologics necessitates the use of sophisticated tools like mass spectrometry and chromatography to ensure accurate characterization. This demand is intensified by the shift toward personalized medicine, where protein profiling plays a critical role in tailoring treatments to individual patients. Consequently, pharmaceutical companies and research institutions are investing in cutting-edge technologies to meet the rising demand for reliable protein identification, fostering continued market growth.

Key Market Players

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Eurofins Scientific
  • Merck KGAA
  • Promega Corporation
  • Qiagen N.V.
  • Sartorius AG

Report Scope:

In this report, the Global Protein Identification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Identification Market, By Product & Services:

  • Consumables
  • Instruments
  • Services

Protein Identification Market, By Application:

  • Drug Discovery & Development
  • Clinical Diagnosis
  • Others

Protein Identification Market, By End-Use:

  • Pharmaceuticals & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

Protein Identification Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Identification Market.

Available Customizations:

Global Protein Identification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Protein Identification Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Consumables, Instruments, Services)
    • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Protein Identification Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Identification Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Mexico Protein Identification Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Canada Protein Identification Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Protein Identification Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Protein Identification Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. Germany Protein Identification Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. United Kingdom Protein Identification Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. Italy Protein Identification Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Protein Identification Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia-Pacific Protein Identification Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Protein Identification Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Protein Identification Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. South Korea Protein Identification Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. Japan Protein Identification Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Protein Identification Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. South America Protein Identification Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Protein Identification Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. Argentina Protein Identification Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. Colombia Protein Identification Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. Middle East and Africa Protein Identification Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Protein Identification Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Saudi Arabia Protein Identification Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. UAE Protein Identification Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Agilent Technologies, Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Bio-Rad Laboratories, Inc.
  • 14.3. Bruker Corporation
  • 14.4. Thermo Fisher Scientific Inc.
  • 14.5. Danaher Corporation
  • 14.6. Eurofins Scientific
  • 14.7. Merck KGAA
  • 14.8. Promega Corporation
  • 14.9. Qiagen N.V.
  • 14.10. Sartorius AG

15. Strategic Recommendations

16. About Us & Disclaimer